$125.00
KPV is a naturally occurring peptide fragment of the alpha-melanocyte-stimulating hormone (α-MSH) that has been studied for its potential role in supporting immune function, inflammation regulation, and gut health.
KPV Capsules 500mcg (Lysine-Proline-Valine) is an advanced, high-purity oral tripeptide formulation derived from alpha-MSH, engineered to study potent anti-inflammatory, immunomodulatory, and gastrointestinal barrier restoration cascades. By directly inhibiting NF-kB nuclear translocation and suppressing pro-inflammatory cytokine expression without inducing melanogenesis, this precisely standardized 500mcg capsule format stands as a premier investigative tool for tracking mucosal lining repair, tight junction stabilization, and systemic tissue-level stress mitigation in laboratory models.
Supplied as stable, precisely standardized 500mcg research capsules. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade KPV Capsules (500mcg), an advanced oral research formulation containing a highly purified synthetic tripeptide composed of the amino acid sequence Lysine-Proline-Valine. Structurally modeled after the active C-terminal fragment of Alpha-Melanocyte Stimulating Hormone (α-MSH), KPV is intensively investigated within molecular immunology and gastroenterology for its profound anti-inflammatory and immunomodulatory properties. This precise 500mcg oral capsule format serves as an elite investigative tool for exploring cellular barrier restoration, tight junction optimization, and targeted mucosal cytokine suppression.
### Mechanism of Action
KPV operates through distinct intracellular pathways to modulate systemic and localized inflammatory stress states:
* **NF-kB Pathway Downregulation:** Research indicates KPV enters target cells where it directly inhibits the translocation and activation of Nuclear Factor Kappa B (NF-kB). By turning off this master inflammatory switch, it downregulates the downstream transcription of pro-inflammatory cytokines, including TNF-alpha, IL-1 beta, and IL-6.
* **Intestinal & Mucosal Barrier Stabilization:** In inflammatory models, KPV is observed tracking the preservation of enterocyte structural integrity, upregulating tight junction protein expressions, and mitigating lumen stress profiles to study intestinal permeability boundaries.
* **Wound Healing & Structural Remodeling:** It interacts closely with structural fibroblasts to modulate collagen deposition mechanics. Preclinical evaluation suggests KPV balances early-stage inflammation to promote clean, hyperplastic tissue remodeling while minimizing atypical scar tissue formation.
* **Non-Melanotropic Signaling Architecture:** Unlike full-length alpha-MSH, the truncated KPV tripeptide chain does not activate melanocortin-1 receptors (MC1R), allowing researchers to study systemic immune modulation without triggering melanogenesis or skin pigmentation changes.
### Research Applications
In preclinical and in vitro laboratory models, KPV 500mcg capsules are actively utilized to investigate:
* Localized gastrointestinal inflammatory responses, colitis/IBD cellular trauma, and mucosal layer repair mechanics.
* Advanced systemic immunomodulation, mast cell stabilization, and targeted cytokine suppression.
* Accelerated soft tissue wound healing, collagen cross-linking kinetics, and fibroblastic structural balancing.
* The comparative baseline bioavailability, absorption kinetics, and stability of oral tripeptide delivery systems.
Our KPV Capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, high chemical purity, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
